Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk (Q28244692)

15

object named as

Margaret S Pepe

0 references

Wolff Schmiegel

18

object named as

Wolff Schmiegel

0 references

author name string

Karsten Schulmann

1

0 references

Anca Sterian

2

0 references

Jing Yin

4

0 references

Fumiaki Sato

5

0 references

Yan Xu

6

0 references

Andreea Olaru

7

0 references

Suna Wang

8

0 references

Yuriko Mori

9

0 references

Elena Deacu

10

0 references

James Hamilton

11

0 references

Takatsugu Kan

12

0 references

Mark J Krasna

13

0 references

David G Beer

14

0 references

John M Abraham

16

0 references

Ziding Feng

17

0 references

Bruce D Greenwald

19

0 references

Stephen J Meltzer

Evolution of neoplastic cell lineages in Barrett oesophagus

20

0 references

language of work or name

English

0 references

publication date

9 June 2005

0 references

published in

Oncogene

0 references

volume

24

0 references

issue

25

0 references

page(s)

4138-48

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208598

Causal relationship between the loss of RUNX3 expression and gastric cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208598

Biallelic inactivation of the RIZ1 gene in human gastric cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208598

Gene silencing in cancer in association with promoter hypermethylation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Chemoprevention for Barrett's esophagus trial. Design and outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

Tumor suppressor activity of RUNX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Adenocarcinoma of the esophagogastric junction and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Surveillance and survival in Barrett's adenocarcinomas: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Barrett's esophagus: development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

The rising trend in oesophageal adenocarcinoma and gastric cardia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Adenocarcinomas arising in tongues or short segments of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208598

7 January 2021